Clinical trials data
Continuous Performance Test in ADHD trials: 123 registered studies
Every registered ADHD study on ClinicalTrials.gov that names the Continuous Performance Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered ADHD studies name it in an outcome measure
- 123
- Name it in a primary outcome, 46%
- 56 of 123
Tests named in the same studies
- 1
AX Continuous Performance Test36 studies, 0 as a primary outcome
- 2
Digit Span Test22 studies, 8 as a primary outcome
- 3
Go/No-Go Task16 studies, 9 as a primary outcome
- 4
N-Back Task9 studies, 5 as a primary outcome
- 5
Stroop Color-Word Test8 studies, 2 as a primary outcome
- 6
Stop-Signal Task6 studies, 3 as a primary outcome
- 7
Card Sorting Test (Berg)6 studies, 1 as a primary outcome
- 8
Verbal Fluency4 studies, 2 as a primary outcome
- 9
Corsi Block-Tapping Test4 studies, 1 as a primary outcome
- 10
Trail Making Test4 studies, 0 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 1 | 1 |
| 2005 | 3 | 1 |
| 2006 | 2 | 1 |
| 2007 | 2 | 1 |
| 2008 | 2 | 1 |
| 2009 | 6 | 3 |
| 2010 | 0 | 0 |
| 2011 | 4 | 1 |
| 2012 | 6 | 2 |
| 2013 | 3 | 2 |
| 2014 | 5 | 3 |
| 2015 | 6 | 2 |
| 2016 | 8 | 2 |
| 2017 | 10 | 4 |
| 2018 | 7 | 2 |
| 2019 | 7 | 1 |
| 2020 | 8 | 5 |
| 2021 | 6 | 3 |
| 2022 | 6 | 5 |
| 2023 | 7 | 4 |
| 2024 | 10 | 4 |
| 2025 | 7 | 6 |
| 2026 | 4 | 1 |
Phases and study sizes
By phase
- Early phase 17 studies, 3 as a primary outcome
- Phase 14 studies, 3 as a primary outcome
- Phase 1/23 studies, 0 as a primary outcome
- Phase 26 studies, 4 as a primary outcome
- Phase 2/31 studies, 1 as a primary outcome
- Phase 311 studies, 4 as a primary outcome
- Phase 415 studies, 6 as a primary outcome
- Not applicable62 studies, 29 as a primary outcome
- Observational14 studies, 6 as a primary outcome
Participants per study
- Phase 364 median, 37 to 199
- Phase 489 median, 33 to 140
- Not applicable70 median, 35 to 108
- Observational202 median, 86 to 343
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 3 | 11 | 64 | 37 to 199 |
| Phase 4 | 15 | 89 | 33 to 140 |
| Not applicable | 60 | 70 | 35 to 108 |
| Observational | 14 | 202 | 86 to 343 |
When ADHD trials measure it
Latest time point of each outcome
- Within a day19 outcomes, 7 as a primary outcome
- Up to 4 weeks23 outcomes, 11 as a primary outcome
- 1 to 3 months46 outcomes, 26 as a primary outcome
- 3 to 6 months13 outcomes, 5 as a primary outcome
- 6 to 12 months9 outcomes, 1 as a primary outcome
- 1 to 2 years2 outcomes, 1 as a primary outcome
- Over 2 years2 outcomes, 0 as a primary outcome
- No duration given8 outcomes, 5 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
114 of the 122 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting13 studies, 4 as a primary outcome
- Not yet recruiting4 studies, 1 as a primary outcome
- Active, not recruiting1 studies, 0 as a primary outcome
- Completed77 studies, 35 as a primary outcome
- Stopped early9 studies, 6 as a primary outcome
- Status unknown19 studies, 10 as a primary outcome
What they test
- Behavioral26 studies, 12 as a primary outcome
- Drug47 studies, 19 as a primary outcome
- Device16 studies, 9 as a primary outcome
- Dietary supplement19 studies, 9 as a primary outcome
- Procedure3 studies, 1 as a primary outcome
- Diagnostic test1 studies, 1 as a primary outcome
- Biological1 studies, 1 as a primary outcome
- Other31 studies, 16 as a primary outcome
- None given5 studies, 1 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States45 studies, 25 as a primary outcome
- Taiwan15 studies, 6 as a primary outcome
- Spain9 studies, 2 as a primary outcome
- France7 studies, 0 as a primary outcome
- Germany7 studies, 1 as a primary outcome
- Hong Kong5 studies, 2 as a primary outcome
- United Kingdom4 studies, 2 as a primary outcome
- Brazil3 studies, 1 as a primary outcome
- China3 studies, 2 as a primary outcome
- Egypt3 studies, 1 as a primary outcome
- Israel3 studies, 1 as a primary outcome
- Netherlands3 studies, 1 as a primary outcome
24 countries in all. A study with sites in several counts in each; 6 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed ADHD studies that name the Continuous Performance Test: 37 of 77, 48%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed ADHD studies that name the Continuous Performance Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 8, 10% | 776, 10% |
| Results on ClinicalTrials.gov only | 15, 19% | 1,139, 14% |
| A results paper only | 14, 18% | 1,711, 22% |
| Neither | 40, 52% | 4,327, 54% |
The 123 studies
123 studies match. 56 name the Continuous Performance Test in a primary outcome. Median size 71 participants. Median time to the primary outcome: 8 weeks.
Loading 123 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 that started before 2000 and 1 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 1 | 1 |
| 2005 | 3 | 1 |
| 2006 | 2 | 1 |
| 2007 | 2 | 1 |
| 2008 | 2 | 1 |
| 2009 | 6 | 3 |
| 2010 | 0 | 0 |
| 2011 | 4 | 1 |
| 2012 | 6 | 2 |
| 2013 | 3 | 2 |
| 2014 | 5 | 3 |
| 2015 | 6 | 2 |
| 2016 | 8 | 2 |
| 2017 | 10 | 4 |
| 2018 | 7 | 2 |
| 2019 | 7 | 1 |
| 2020 | 8 | 5 |
| 2021 | 6 | 3 |
| 2022 | 6 | 5 |
| 2023 | 7 | 4 |
| 2024 | 10 | 4 |
| 2025 | 7 | 6 |
| 2026 | 4 | 1 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 19, other 104. Interventional 109, observational 14.
As a primary outcomeSecondary or other outcomeThe Continuous Performance Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07900451 | Start2026 | PhaseObservational | ConditionsADHD | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07900048 | Start2026 | PhaseNot applicable | ConditionsADHD | Participants100 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07767617 | Start2026 | PhaseNot applicable | ConditionsADHD, Sleep and sleep disorders | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07595783 | Start2024 | PhaseNot applicable | ConditionsADHD | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07521449 | Start2023 | PhaseNot applicable | ConditionsADHD | Participants45 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07419659 | Start2026 | PhaseNot applicable | ConditionsADHD | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07364331 | Start2021 | PhaseNot applicable | ConditionsADHD | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07348562 | Start2021 | PhaseNot applicable | ConditionsADHD | Participants15 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07333339 | Start2025 | PhaseObservational | ConditionsADHD | Participants174 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07228650 | Start2025 | PhaseObservational | ConditionsADHD | Participants500 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07203092 | Start2025 | PhaseNot applicable | ConditionsADHD | Participants140 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07180602 | Start2025 | PhaseNot applicable | ConditionsADHD | ParticipantsNot given | Lead sponsorIndustry | StatusStopped early | Library tests named
|
| NCT07147894 | Start2025 | PhaseNot applicable | ConditionsADHD | Participants780 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07061470 | Start2027 | PhasePhase 1/2 | ConditionsADHD, Sleep and sleep disorders | Participants70 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07039903 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder, ADHD | Participants68 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06940089 | Start2025 | PhaseNot applicable | ConditionsADHD, Epilepsy | ParticipantsNot given | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT06743763 | Start2024 | PhaseNot applicable | ConditionsADHD | Participants110 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06657469 | Start2017 | PhaseNot applicable | ConditionsADHD | Participants80 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06632249 | Start2024 | PhaseNot applicable | ConditionsADHD | Participants98 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06594536 | Start2024 | PhaseNot applicable | ConditionsADHD | Participants70 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06496685 | Start2018 | PhaseNot applicable | ConditionsADHD | Participants36 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06491836 | Start2024 | PhaseNot applicable | ConditionsADHD | Participants50 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06369714 | Start2023 | PhaseNot applicable | ConditionsADHD | Participants210 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06256003 | Start2024 | PhaseNot applicable | ConditionsADHD | Participants140 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT06226584 | Start2024 | PhaseNot applicable | ConditionsADHD | Participants30 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
Questions, answered from the data
How many ADHD trials use the Continuous Performance Test?
123 registered ADHD studies on ClinicalTrials.gov name it in an outcome measure, 56 of them in a primary outcome: 34% of the condition's 357 studies with a cognitive outcome, against 4% of all of them. It is the test ADHD trials name most.
Which tests do ADHD trials use with the Continuous Performance Test?
The AX Continuous Performance Test (36 studies), the Digit Span Test (22 studies) and the Go/No-Go Task (16 studies).
When do ADHD trials measure the Continuous Performance Test?
Half of the primary outcomes that name the Continuous Performance Test are measured within 8 weeks of the start, and the middle half from 3 weeks to 13 weeks. 51 primary outcomes give a duration.
How many completed ADHD trials that use the Continuous Performance Test have reported results?
37 of the 77 completed studies that name it, 48%, have reported results: 23 posted them on ClinicalTrials.gov, 22 have a results paper linked to the registry record, and 8 did both. The other 40 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Continuous Performance Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.